Add
ISPH to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| ISPH > SEC Filings for ISPH > Form 8-K on 22-Sep-2009 | All Recent SEC Filings |
22-Sep-2009
Regulation FD Disclosure, Financial Statements and Exhibits
On September 22, 2009, Inspire Pharmaceuticals, Inc. (the "Company") will make a presentation at the UBS Global Life Science Conference in New York, New York. The full presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The furnishing of the attached information is not an admission as to the materiality of any information set forth therein.
The information in this Form 8-K and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
(d) Exhibits
No. Description
99.1 Presentation made on September 22, 2009 at the UBS Global Life Science
Conference in New York, New York.
|
|
|